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A series of in vivo experiments was undertaken for the purpose of 
determining what effects prostaglandin F2o( compound would have on a 
number of endocrine organs and reproductive structures of immature female 
rats. The pituitary, thyroid, uterus, vaginal canalization, ovarian 
progesterone biosynthesis and body weights were carefully analyzed. 
The procedures included the chronic administration of PGF2o<. (0.075 mg, 
BID) in 30 twenty-two day old female albino rats. On days 27, 33 and 
. 
37, ten rats were necropsied and their body and organ weights were 
recorded. Vaginal canalization was noted at this time. All tissues 
were formalin-fixed while the ovaries were quick frozen in liquid nit-
rogen for progesterone biosynthesis determination, by way of semi-quanti-
tatively assessing the histochemical detection and intensities of preg-
nenolone-3B-hydroxysteroid dehydrogenase. 
Other experimental groups that paralleled the prostaglandin group 
included a prostaglandin antagonist (aspirin), and two adenohypophyseal 
gonadotropins, Follicle Stimulating Hormone (FSH) and Luteinizing Hormone 
(UI). The controls included a non-injected group and an alcohol (aspirin 
vehicle) injected group. 
The results indicated that the basic biological responses of immature 
rats to PGF2o( administration included increased ovarian progesterone 
biosynthesis as determined by enzyme histochemical techniques, and pre-
mature sexual development as witnessed by early vaginal canalization. 
BOth of these responses were significant and were related to the exogenous 
prostaglandin compound. No significant differences could be detected 
either gravimetrically or histologically among the thyroid glands, pit-
uitary glands and uteri of the prostaglandin group versus the control 
groups. 
The aspirin group revealed stunted growths and delayed sexual de-
velopment, but aspirin toxicity, however slight, could not be ruled out. 
The selected gonadotropins, FSH and UI, yielded variable responses 
which raised doubts about their purity. FSH, however, did show a pro-
gressively decreasing amount of ovarian progesterone biosynthesis activity, 
while the LH injected group could not be distinguished from the normal 
control group. 
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INTRODUCTION 
prostaglandins are hormone-like substances that are widely distrib-
uted in human and animal tissues. They are believed to be intracellular, 
metabolic regulators that stimulate or inhibit the action of many hormones. 
Their remarkably wide range of pharmacologic effects has excited world-
wide scientific interest. On the horizon now are potential medical uses 
of prostaglandins for numerous and diverse clinical problems, ~·a· labor 
induction, therapeutic abortion, contraception and hypertension control. 
Prostaglandins are 20-carbon acidic lipids whose metabolic precursors 
are the essential fatty acids. There are fourteen known prostaglandins; 
they are widely distributed in small amounts throughout the animal king-
dom. Although very rapidly metabolized, prostaglandins are one of the 
most potent chemicals ever discovered, one millionth of a gram producing 
marked effects. 
A rather confusing combination of Greek and Roman letters is used 
to identify these compounds, i ~· A, E1 , F2~. Of the fourteen prosta-
glandins, thirteen occur in man, ~ith the highest concentration in 
human seminal fluid. Their wide range of physiologic effects can be 
shown by prostaglandin E2 , the most thoroughly studied, which not only 
stimulates smooth muscle, lowers blood pressure, inhibits gastric sec-
retions and inhibits platelet aggregation, but also inhibits lipolysis 
and acts as a nasal vasoconstrictor, bronchodilator, causes sedation, 
produces optical miosis, and increases intraocular pressure. In general, 
the E and A groups of prostaglandins have vasodepressor effects while the 
---
Up tends to raise blood pressure. p gro 
are used for therapeutic abortions. 
2 
Both groups will induce labor and 
There has been much interest in prostaglandin research in recent years 
mainly due to larger supplies of a purer substance. The greater interests 
into the effects of prostaglandins at the present time seem to be focused 
on the female reproductive systems of mature mammals. Little interest, 
however, has been given to the effects of prostaglandins on immature 
mammals. Therefore, it seemed pertinent to initiate some studies and 
experimental trials which could provide more detailed information con-
cerning the nature of the effects of prostaglandins during the period of 
transition from immaturity to maturity. 
For determining a possible action site of prostaglandins, a prosta-
glandin antagonist, acetylsalicylic acid (aspirin), was used in one 
experimental trial group. Two gonadotropins, Follicle Stimulating Hor-
mone (FSH) and Luteinizing Hormone (LR), were used in additional experi-
mental groups to differentiate any similarity between their responses 
and the prostaglandin responses. 
The organs selected for study were the pituitary, thyroid and uterus. 
Vaginal canalization was used as the index of puberty and frozen ovaries 
were processed to study possible progesterone biosynthesis activity. 
There are no classical monographs on this subject to refer to, and 
this thesis is intended to add new lines of information so that we can 
better understand the nature of PGF2o'. • This study is the first such 
attempt to record the chronic effects of prostaglandins on the selected 
-- 3 
organ systems of developing immature rats by thorough assessments of the 
sequelae of the changes over short time intervals. Such a study can make 
a significant contribution to the knowledge of prostaglandin research 




REVIEW OF THE LITERATURE 
The proliferation of prostaglandin research is a fairly recent de-
velopment. Three Swedish investigators did the pioneer work: Professor 
U.S. von Euler, coiner of the term "prostaglandin"; Sune Bergstrom and 
isengt samuelsson. Isolation and determination of the structure of PGE1 
and PGF1 , eleven years ago by Bergstrom (1962), gave a great impetus 
to research work. 
During the first decade after prostaglandins were discovered in 
1930 by Kurzrok and Lieb, all research was conducted in a single lab-
oratory,!.-~· that of Professor von Euler. After World war II, Bergstrom 
took on the job of attempting to isolate, identify and purify the sub-
stances. In 1957, the Bergstrom team isolated PGE1 and PGF1 in pure 
crustalline form and during the next five years developed the advanced 
chromatographic techniques to precisely define the chemical structure of 
their compounds. 
The impetus for further biological work resulted from the elegant 
isolation and chemical identification achieved by Bergstrom, Sjovall, 
Samuelsson and their co-wrokers. Bergstrom and Sjovall (1957) isolated 
two compounds which behaved differently on partition between ether and 
an aqueous phosphate buffer. The one more soluble in ether was called 
prostaglandin E (PGE), the other, more soluble in phosphate buffer was 
called prostaglandin F (PGF). These compounds were assigned the empirical 
formulae c20H34o5 and c20H36o5 respectively. Total chemical synthesis 
of all the major natural prostaglandins is now possible as a result of 
the elegant methods devised by E. Corey, ~ !.!_. (1969). These have 
already proven feasible for commercial production. 
5 
It is clear that within the next decade thousands of prostaglandin 
analogues will be synthesized. One can, therefore, anticipate that 
compounds with more specific and more potent biological activities, as 
well as antagonists to prostaglandins, will become available for both 
clinical and research use. Prostaglandin antagonists, like aspirin and 
indomethacin, are anti-inflammatory drugs which can block prostaglandin 
synthesis (Smith and Willis, 1971; vane, 1971). 
The basic question in prostaglandin research is to define the 
normal function of this wide array of substances. This remains, for the 
most part, not answered, but many theories exist; facilitating ejaculation 
(von Euler, 196 7), a menstrual "stimulant" (Pickles, 1959), a role in 
parturition (Karim,~ al., 1969), and an anti-hypertensive renal 
endocrine function (Lee~!.!_., 1971). 
Major contributions to knowledge of the metabolic pathways of the 
prostaglandins came from Hamberg and Samuelsson who, in 1966, isolated 
and identified the eight naturally occurring metabolites of the six 
primary prostaglandins. Steinberg and his co-workers (1963) made the 
original observation that PGEl inhibits hormone-induced lipolysis. The 
conclusions that were made included the possibilities that PGE 1 inhibits 
6 
the enzyme adenyl cyclase, and that this inhibition is an indirect action 
c111mwell and shaw, 1970). 
on the other hand, there is abundant evidence that pn many tissues, 
p~ compounds, although affecting adenyl cyclase, do not inhibit the 
related hortn)ne but instead mimics that hormone's action. Thus PGE2 , 
like corticotropin, stimulates corticosteroidogenesis (Flack~ al., 1969). 
IC11neko ~al., (1969) has shown PGE 1 to mimic the action of thyroid 
stimulating hormone (TSH). PGE1 also stimulates insulin secretion with 
cyclic AMP acting as the mediator. It may be concluded that interactions 
between PGE compounds and adenyl cyclase may underlie many of the effects 
produced by prostaglandins but no hypothesis has yet explained the mode 
of action of the PGF or PGA compounds. 
It has been hypothesized that prostaglandins are probably synthe-
sized in all or in most cells and in all species and that the primary 
mechanism of action of prostaglandins is on the plasma membrane and its 
association with adenyl cyclase and adenosine 3', 5'-monophosphate (Cyclic 
AMP) (Butcher, ~ al., 196 7). Cyclic AMP,, described as a "second messen-
ger system" - the hormone being the first messenger - is believed to 
mediate most, if not all, hormone actions. Cellular regulation of the 
response of a tissue to hortn)nal stimulation by prostaglandins has also 
been indicated, since exogenous prostaglandins can modify the hormonal 
responses of the tissue (Shio, ~ !!.!,., 1971). 
-
7 
prostaglandins can increase cyclic AMP levels in many tissues in 
what appears to be a nonspecific manner. No qualitative differences 
have been observed between the groups of prostaglandins in their ability 
to increase the intracellular accumulation of cyclic AMP, but Butcher, 
1 (1967), has found the PGE group to be generally more potent than et a • , 
--
the PGF series. 
studies by Ramwell and Shaw (1970) regarding the effect of tissue· 
stimulation on endogenous prostaglandins have indicated that more prosta-
$1andins are released than can be extracted, suggesting the activation 
of a biosynthetic process rather than the release from a preformed store. 
It has, therefore, been hypothesized that prostaglandins interact with 
cyclic AMP, thereby mimicking certain hormones - oxytocin, ACTH, follicle 
stimulating hormone. 
It is becoming clearer that prostaglandins are involved in the re-
sponse of a tissue to hormonal stimulation but the determination of the 
exact role awaits elucidation of whether the biosynthesis and release of 
prostaglandins results from a direct effect of the hormones or whether 
it is secondary to changes in cyclic AMP levels. 
I. Circulation of Prostaglandins 
Prostaglandins are released into the circulation from different 
organs, but a very high proportion of PGE and PGF compounds are metabolized 
on one circulation through the lungs. 
! ~; 
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Fifteen minutes after the intravenous injection of PGF2~ in mice, 
net al., (1967),showed most of the compound was concentrated in the 
aree - -
liver, kidneys and subcutaneous connective tissue. No significant 
amounts could be demonstrated in the other organs including the endocrine 
glands. PGF2« does reach the uterine venous blood, however, under 
physiological conditions, and has been identified as simulating the 
action of luteolysin (Poyser,~ al., 1970; Blatchley~ al., 1971; 
Bland,~!!_., 1971). PGF2~, although stable in blood, is 95% removed 
from the circulation on one passage through the lungs; furthermore, 80% 
of the prostaglandins are removed by the liver via the portal system 
(Ferreira and vane, 1967). 
II. Prostaglandi i Actions on the Thyroid. 
very little has been done regarding the effects of prostaglandins 
on the thyroid gland. In canine thyroid slices, PGE 1 mimics the actions 
of thyroid stimulating hormone (TSH), (Onaya and Solomon, 1970; Zor et 
!.!·• 1960). It is suggested, therefore, that PGE1 is functional in the 
secretion of thyroid hormone which is initiated by TSH (G~imley, ~al., 
1969). It should.be mentioned that these were in vitro studies and only 
speculations can be made on the in vivo environment. 
---
III. Prostaglandin Actions on the Uterus. 
Extensive studies of prostaglandins and the uterus have progressed 
to therapeutic applications of the prostaglandins and clinical trials. 
9 
JCl&rim (1971) has performed clinical trials in Uganda and has reported that 
GF A administered orally will induce labor in the later stages p(J!2 and P 2"" 
of pregnancy in humans without serious side effects. Investigations 
concerning prostaglandins and the uterus have attempted to determine 
their role in the pregnant and non-pregnant uterus. 
The non-pregnant uterus is stimulated by PGF1~ and PGF2~ compounds 
which are found in menstrual fluids; while the PGE compounds, found in 
high concentrations in seminal fluids, inhibit myometrial activity 
(Bygdeman and Hamberg, 1967). This general statement must be modified in 
view of investigations which show that the stage of the ovarian cycle 
is important. Human myometrium is more sensitive to inhibition by PGE 
at midcycle near ovulation (Eliasson, 1963) and more sensitive to PGF2~ 
stimulation just before menstruation (Pickles,~ al., 1965) and during 
pregnancy (von Dorp, ~al., 1964). This is probably related to the 
changing levels of the ovarian steroids. It is suggested, therefore, 
that the physiologic role of PGE in semen is to facilitate sperm migra-
tion and subsequent capacitation and fertilization. 
The pregnant uterus, in contrast to the non-pregnant uterus, responds 
differently to the prostaglandin compounds. Both PGE2 and PGF2~ are 
apasmogenic on upper uterine muscle strips, but inactive on lower muscle 
segments (Embrey and Morrison, 1968). Additional follow-up studies by 
R'ilrim (1968) showed that PGF2~ was consistently found in venous blood 
of patients in labor, but absent in women who needed surgical deliveries 
or those women not in labor. The source of this PGF2~ , according to 
10 
IOlrim and Devlin (1967), is the placenta. 
As the investigation and research continues into the effects of 
prostaglandins on the uterus, interesting speculations have arisen, all 
of which are still under serious consideration. 
l{irton ~al., (1970) has proven the successful role of PGF2~ as 
8 contraceptive when given after ovulation in primates. They have shown 
this effect to be caused by the luteolytic properties of PGF2~ and have 
hypothesized this to be the specific factor which normally causes the 
. 
corpus luteum to regress each month if no pregnancy occurs. This has 
opened a new approach to female contraception whereby prostaglandins may 
be administered once each month as compared to the conventional birth 
control pills (Karim and Sharma, 1971). 
Bygdeman and Samuelsson (1966) have investigated PGE 1s role into 
human male infertility and have suggested that 8% of male infertility 
might be due to PGE deficiency. PGE 1s role in preventing gastric and 
duodenal ulcers in rats and dogs has been strongly suggested by Shaw 
and Ramwell (1968). When administered as aerosols, PGE1 will act as a 
bronchodilator according to Jackson (1970) with this decongestant, such 
effect lasting up to 14 hours. 
The PGA group has been selectively researched into the area of hypo-
tensive effects because they are not quickly metabolized and inactivated 
in contrast to the PGE and PGF groups. Lee~!!,., (1971) has shown the 
marked reduction in blood pressure in hypertensive patients by the infusion 
Of PGA.. 
11 
A final comment to be made concerning the effects of prostaglandins 
on the endocrine and reproductive systems is that many statements and 
facts are being made, but that no acceptable proven hypothesis governing 
prostaglandin action thus far has been established. Investigations have 
only resulted in speculations. The intensity of research into this 
area will undeniably shed new light on their true significance. Many 
questions remain unanswered. 
12 
MATERIALS AND METHODS 
Aun~i~ma::::.:l~s_.;..a_n_d_H_o~u_s_in_g~. 1. ::;,... 
A total of 190 immature (21 day old) Sprague-Dawley derived female 
rats (tocke-Erickson Laboratories, Maywood, Illinois) were separated 
randomly into 19 experimental groups. Rats were housed five to a unit 
in clear plastic "shoe-box" shaped cages (10.5 X 19 X 8.5 inches) on San-
i·cell bedding (Paxton Laboratories, Paxton, Illinois). Feed (Purina I.ab 
Chow) and water were provided ad libitum. They were all housed in the 
same environmentally controlled room where the temperature (72±2° F), 
humidity (43±5%) and a 12 hour light cycle remained constant. 
11. Experimental Groups. 
1. All injections were given subcutaneously using a tuberculin 
syringe and a 26 gauge needle; they were given twice daily (8 a.m. and 
4 p.m.). Two major control groups were defined: a non-injected normal 
control group and an alcohol-injected control group injected with 0.25 
cc of 10% ethanol. This was necessary because alcohol was the vehicle 
for the acetylsalicylic acid~ Ten non-injected controls were necropsied 
at 22 days to establish baseline values. Then, successive groups of 10 
rats from both control groups were necropsied at ages of 27, 33 and 37 
days, i·~· after 5, 11 and 15 days of treatment. 
2. The prostaglandin group was injected with 0.075 mg of PGF20, 
twice daily (0.075 cc,BID) from day 22 through the day prior to termination 
on days 27, 33 and 37. The PGF2~ was delivered frozen at a concentration 
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of 10 rog/ml in. a phosphate buffer from G.D. Searle Co., Skokie, Illinois. 
This was further diluted to a concentration of 0.1 mg/ml with a phosphate 
Solution and then dispensed into 1.00 cc aliquots and refrozen at J>uffer 
•6o" c until used. 
3. The aspirin (acetylsalicylic acid) was dissolved with 10% 
ethanol and injected at dosages of 5 mg (0.25 cc) BID. The injections 
were started on day 22 and continued up to the termination on days 27, 
33 and 37. 
4. The LH (Schwarz-Mann, Orangeburg, New York) injected rats were 
given 0.125 Armour Unit (LH-ovine, Armour, 277-80 equivalent to NIH-LR-Si) 
BD> from day 22 until time of sacrifice on days 27, 33 and 37. The LH 
was received lyopholized and was reconstituted with sterile saline to 
··"-·~·· . 
deliver a dose of 0.05 cc. 
5. The FSH (Schwarz-Mann, Orangeburg, New York) injected rats were 
given 0.25 Armour Unit (FSH-porcine, Armour, 264-15lx equivalent to 0.5 
NIH·FSH-S1), BID in a 0.05 cc dose. The injections began on day 22 and 
continued up to termination on days 27, 33 and 37. 
The age of the immature rat and this determination of the necropsy 
dates were made to coincide with the specific growth periods of the repro-
ductive system as described by Kasprow (1969). 
III. Procedures. 
Rats were euthanized and necropsied after recording body weight to 
nearest gram on a direct reading torsion balance and killing by ether 
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thesia followed by decapitation. Vaginal openings were recorded at anes 
time of necropsy. The pituitary, thyroid, ovaries and uterus were dis-
iected free and weighed to the nearest 0.2 mg on a Roller-Smith type tor-
sion balance. In cases where the uterus wad distended with fluid, incis-
ions were made to drain the fluid and the uterus was blotted dry with 
bibulous paper. After weighing, half of the thyroids, uteri and ovaries 
were _fixed in buffered formalin and the other half were quick frozen in 
liquid nitrogen and stored at -60° C. The pituitaries were fixed in a 
Jouin's-Holland solution. 
The formalin-fixed tissues were then washed, dehydrated, cleared and 
embedded in paraffin blocks. Sections were taken at six microns and 
stained with the standard Harris hematoxylon and eosin stain. Photo-
micrographs were taken using a Wild microscope and Polaroid 107 type 
film at lOOX magnifications for comparison. 
The ovaries that were frozen were sectioned at eight microns and 
incubated for 3~ hours in a media containing pregnenolone, propylene glycol, 
nictotinamide-adenine dinucleotide (NAD) and nitro blue tetrazolium chloride 
(Nitro-BT), all in a phosphate buffer solution (pH 7.4) (Wattenberg, 1958). 
A set of companion ovarian sections were incubated in media without preg-
nenolone and served as control groups. Polaroid photomicrographs were 
taken of the incubated sections to determine and neasure the semi-quanti-
tative reactions. 
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This particular technique allows for the localization and semi-quan-
tion of the enzyme pregnenolone-3p-hydroxysteroid dehydrogenase (P-tita 
0118
• 3p-HSD), which is indicative of active progesterone biosynthesis. 
'l'be intensity of activity was rated on a scale of 0 to +5, depending on 
the degree of monoformazan and diformazan precipitate on the ovarian 
tissue, (Plates I-III). 
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EXPERIMENTAL RESULTS 
l· 9'ntro 1 Groups. 
Gravimetric analyses of body, thyroid, pituitary and uterine weights 
of the innnature female rats revealed a linear progression of increasing 
weights. The :OOdy, pituitary and uterine weights show a greater than 100% 
increase in size from day 22 to day 33, for body weights, 41 mg to 92 mg; 
a 100% increase for pituitary weights, 2.2 mg to 4.4 mg; and a greater than 
300% increase for uterine weights, 20.2 mg to 85.2 mg (Table I). The thy-
roid gland increased approximately 80% during this same time period, i.e. 
4. 7 to 8.4 mg. 
As would normally be expected the mg% values of the thyroid and 
pituitary glands began to decline as the rats passed the 27th day; the 
gland growth slowing while the body growth continued, 11.5 to 7.9 and 
5.4 to 4.2 respectively. The uterine mg% values became rather constant 
past the 27th day, i·~· 92.0 at 33 days and 92.5 at 37 days. The standard 
deviations of these uterine weights increased considerably as the animal 
matured because of the beginning hormonal activity of their reproductive 
systems, and such variations can be expected in this age range (Kasprow, 
1969). 
From the tabular data, one observes the fact that up to day 33, 
100% of the animals were sexually immature, as manifested by closed vaginae 
Thereafter, by day 37, 100% became sexually mature. This five day range 
of vaginal canalization is acceptable as a normal range when the animals 
are of an inbred strain and housed together (Locke, 1971). 
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The pregnenolone-3p-HSD activity displayed by the ovaries of the con-
1 ro ups was of minimal intensity at 27 days with a 75% increase in tro g 
activity intensities by day 33 (Table V, Text Figure V). This proges-
terone biosynthetic capability remained constant from day 33 to day 37. 
It is interesting to recall that the uterine mg% weight also remained 
constant from day 33 to day 37. 
II. prostaglandin Group. 
The body weights of the chronically injected prostaglandin rats 
were always lighter than the controls, but the differences were not sig-
nificant, i·~· 55 gm~ 59 gm at 27 days; 90 ~ 92 at 33 days; 120 vs 123 
at 37 days (Tables I-IV). Gravimetric analysis of the thyroid glands from 
days 22 to 27 showed no significant differences from the control, i·~· 
6.7 mg!! 6.9 mg at day 27; 8.4 ~ 8.4 at day 33; 10.0 ~ 9.6 at day 37. 
The same was true for their mg% values (Text Figure I, and Tables I-IV). 
The pituitary weights were almost identical with those of the control 
groups as were the mg% values, i·~· 3.0 mg vs 3.2 mg at day 27; 4.3 ~ 
4.4 at day 33; 5.2 ~ 5.2 at day 37, (Text Figure II, and Tables I_:-IV). 
The uterine weights of the prostaglandin injected rats were compar-
able at day 27 and became progressively lighter than the controls, !·~· 
34.2 mg~ 34.0 at day 27; 75.9 vs 85.2 at day 33; 107.9 ~--114.2 at day 
37, (Text Figure III and Tables I-IV). No statistical significance could 
be_detected. Needless to say, the large standard deviation values due to 
the sexual maturation and uterine responses may have hidden or masked any 
real growth differences which may have, in fact, existed. Analyzing 
uterine weights during first ovulations may prove an interesting field of 
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endeavor. The. histological observations on all these tissues failed to 
detectable differences from the normal morphology of the controls. 
sbo'W any 
The most significant finding of the PGF~-injected immature female 
rats was the premature sexual maturation which was evidenced by 90% of 
the rats by day 33, (Text Figure IV). In rats, the vaginal opening 
occurs near the time of the first ovulation and is used as an index of 
puberty. on day 33, none of the control vaginae were open and this dif-
ference was significant using the student's t-test (P=<0.001), (Table III). 
BY day 37, all the rats in the prostaglandin and control groups were open. 
The tabulated data of the semi-quantitative histochemical estimates 
of f-one-3p-HSD activity of the PGFio. rat ovaries displays a significantly 
greater intensity of activity on days 27 and 37, than on day 33 when it 
fails to show a similar difference, i.e. 4.0 !!. 1.8 at day 27; 2.3 
!!. 3.0 at day 33; 4.2 ~ 3.0 at day 37, (Text Figure V, Figure V). 
'lbis early progesterone biosynthesis is interesting because it may pro-
vide a clue as to how subcutaneously administered PGF2()(. can exert its 
effects on the biological response of premature sexual maturity as wit-
nessed by the early vaginal canalizations.' 
nI. Aspirin Group. 
Gravimetric analyses of the body weights revealed a consistantly 
lighter weight which was becoming progressively lighter than the controls, 
!·!· 54 gm vs 59 at day 27; 89 vs 92 at day 33; 110 vs 123 at day 37, 
- - -
(Tables I-IV). The general appearance of these rats towards day 37 · 
19 
ted the possibility of an aspirin toxicosis because of the roughened 
augges . 
drJ h8ir coat, mild emaciation and dehydration. But despite this general 
e and smaller weight size, the endocrine gland weights were com-appearanc 
1 to the normal controls if not larger. parab e 
The thyroid gland was variable in its weight comparisons, but none 
were significantly different from the control thyroids, !.·~· 6.0 mg Y!. 
6.9 at day 27; 8.9 vs 8.4 at day 33; 9.2 Y!. 9.6 at day 37. The uterine 
weights of the aspirin injected rats were all lighter than the controls 
but again no statistical significance could be detected because of the 
large values of the standard deviations, !.·~· 26.6 mg Y!. 34.0 mg at day 
27; 70.9 Y!. 85.2 at day 33; 109.3 Y!. 114.2 at day 37, (Tables I-IV, Text 
Figure I). 
The pituitary gland, on the other hand, was somewha,t larger than those 
of the controls on day 27 (3.4 mg Y!. 3.2 mg) and this small difference 
was significant (P=<0.05) (Table II). This was an interesting finding 
because aspirin, a prostaglandin antagonist, blocks the biosynthesis of 
endogenous prostaglandins, and any blockage of prostaglandins would have 
decreased the weight of an end organ, unless a negative feedback mechanism 
,.as operating. This larger value could also be regarded as part of an 
aspirin toxicity phenomena which would render it meaningless for our 
purpcses. The successive values of the pituitary weights on days 33 and 
37_were 4.5 mg and 5.8 mg compared to the control values of 4.4 mg and 
S,2 mg respectively; neither values were significantly different than 
those of the controls, (Tables I-IV, Text Figure II). 
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A delayed sexual maturity was observed in the aspirin-treated rats 
88 
witnessed by the failure of vaginal cana~ization by day 37. Only 
153 of the rats displayed open vaginae by day 37 compared to 100% of the 
control rats, {Text Figure IV). This lag in sexual maturity may have been 
caused by either of two initiating factors. Either the possible aspirin 
toxicity was effective enough in its manifestations to stunt or retard 
normal growth because of its toxicity, or the aspirin used did, in fact, 
block the prostaglandins which are involved with the production of and 
biological responses to the ovarian steroids. To establish this fact, 
further experimental trials must be done; one can' only speculate with 
the results obtained so far. 
The semi-quantitative analyses of the pregnenolone-3~-HSD intensity 
in the ovaries of the aspirin injected rats revealed a variable linear 
relationship between the aspirin and the control groups. The 27 day value 
was greater than the control (2.3 ~ 1.8); the 33 day values were equal 
at 3.0; while the 37 day value was less than that of the control, i.e. 
2.5 !!_ 3.0 respectively. None of these aspirin-elicited values were of 
statistical significance, (Table v, Text Figure V). 
IV. The Follicle Stimulating Hormone {FSH) and Luteinizing Honnone (LR) 
Groups. 
Gravimetric analyses of the FSH and LR groups yielded significant 
differences in the pituitary, thyroid and uterus, body weight and vaginal 
canalization, but the purity of these compounds must be questioned because 
of the Possible contamination with growth factors. The increases in body 
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,,eights in the' FSH and LH groups ranged from 68 g and 65 g ~ 59 g at 27 
~. 
8
• 103 and 101 vs 92 at 33 days; 127 and 126 vs 123 at 37 days, 
u-Y, - -
(Tables I-IV). The 27 day differences were statistically significant 
(P..0.01 and 0.02) after five days of injections while the 37 day varia-
tions were not significantly different. This sudden increase in body size 
and the resulting fall back into the normal range of the control groups 
cannot be explained if these substances were pure compounds~ 
The thyroid data shows the FSH and LH group mg% values to be consis-
tently larger than the controls but analysis showed that these differences 
were not significant. i·~· 6.8 mg and 7.3 mg vs 6.9 mg at day 27; 9.3 
and 10.0 ~ 8.4 at day 33; 10.7 and 10.4 ~ 9.6 at day 37, (Tables I-IV, 
Text Figure I). The pituitary glands showed a similar relationship with 
the values being larger but not significantly larger, i·~· 3.5 mg and 4.1 
Jll8 Y!. 3.2 mg at day 27; 4.9 and 4.9 vs 4.4 at day 33; 6.2 and 6.7 vs 5.2 
at day 37, (Tables I-IV, Text Figure II). These similar weight comparisons 
of the thyroid and pituitary glands to the controls might possibly be ex~ 
plained by the presence of growth hormone factors in the FSH and LH pre-
parations. 
The uterine weights were all significantly larger than the controls, 
which should be expected because of the gonadotropic effects on the 
ovaries and their resulting effects on the uteri, i.e. 49.4 mg and 124.5 
mg!!. 34 mg at 27 days; 149.9 and 204.1 ~ 85.2 at day 33; 147.3 and 161.2 
!!. 114.2 at day 37, (Tables I-IV, Text Figure III). 
22 
premature sexual maturation as seen in the PGF2:'<-injected rats was 
also present in the FSH and LR injected groups; and this was a statistic~ 
ally significant difference from that of the control (P=0.001), (Table 
III, Text Figure IV). One hundred per cent of the rats in each group dis-
played open vaginal canalization at the time of necropsy at day 33. These 
gonadotropic hormones are directly responsible for the early activity of 
the ovary which in turn initiates the uterine and vaginal development via 
the ovarian steroids. This activation of ovarian steroidogenesis may be 
the same method by which the PGF2~ group exerts its effect on premature 
sexual maturity. 
Analyzing the semi-quantitative histochemical estimates data of 
the enzyme converting ovarian precursor of progesterone (P-one-3~-HSD), 
one finds seemingly increased levels of intensities in the 27 day FSH and 
1H groups when compared to the controls, ~-~· 3.2 and 2.3 ~ 1.8, (Table 
V, Text Figure V). These differences, however, were not statistically 
significant. 
The FSH injected rat ovaries show decreased P-one-3~-HSD intensities 
for the 33 and 37 day intervals as compared to controls, ~·~· 2.3 vs 3.0 
and 1.4 vs 3.0 respectively, while the LR injected rat ovaries showed 
similar P-one-3~-HSD intensities, as the control groups, i.e. each had 
values of 3.0, (Table V, Text Figure V). 
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DISCUSSION 
While studying the biological effects of the prostaglandins, one is 
iJDpressed with their wide distribution and their unparalleled ability to 
aiodifY hormone actions, an effect now known to correlate with changes in 
cyclic AMP levels within the different cell types. Cyclic AMP is now con-
sidered the key intracellular mediator in tissue responses to many hor-
mones (Robison~!.!_., 1971). According to the current concept, the hor-
mones are released from their tissue or origin and travel via the circu-
lation to the target tissue where they stimulate adenyl cyclase to catalyze 
the conversion of adenosine triphosphate (ATP) to cyclic AMP, which in 
turn induces the target tissue to respond. The concept is complicated by 
the multiplicity and diversity of the actions reported for cyclic AMP 
and by the actions of other cyclic mononucleotides (Robison~ al.1971). 
Also, the prostaglandins can mimic many of the responses usually attributed 
to cyclic AMP. These interrelationships are neither simple nor well under-
stood. 
Depending on the tissues or organs involved, prostaglandins either 
increase or decrease the synthesis of cyclic AMP by adenyl cyclase or the 
degradation of cyclic AMP by phosphodiesterase. As an oversimplified 
generalization, prostaglandins decrease cyclic AMP in adipose tissue and 
toad bladder (Lipson and Sharp, 1971), and increase cyclic AMP in most 
other tissues. Studies with rat brown fat, and with canine, rabbit and 
human fat, indicate species differences are involved which further co~pli­
cate the picture (Bizzi, ~ !.!_., 1968; Hinman, 1972). Prostaglandins E 
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and F have already been reported to stimulate cyclic AMP formation in the 
. y thyroid and uterus but this work was done in vitro while in pitu1tar , 
i results are still forthcoming (Ramwell and Shaw, 1970). ~~ 
The earlier sexual maturity and increased progesterone biosynthesis 
in the ovaries revealed that the iniected PGF2« did, indeed, have biological 
effects on these immature rats. These experiments, however, revealed no 
biological effects, either gravimetrically or histologically, on the pit-
uitaries, the thyroid glands and the uteri. This in vivo experiment evalu-
ated the response of the animal in total equilibrium with all functioning 
Despite the high rate of deactivation of injected prostaglandins by 
the lungs and liver, enough PGF2 ~ did circulate to influence the ovarian 
1teroidogenesis by day 27. Further investigations into the histochemistry 
~ of the pituitary, thyroid and uterus would be of value to add to the in 
vivo knowledge of prostaglandin effects on immature animals . 
........... 
A factor to consider is that, although the body weights tripled in 
size from day 22 to day 37, the standard daily dose per rat remained con-
ltant at 0.075 mg BID and the delivered dosage per gram of·body weight 
became progressively smaller. This was unavoidable because of the 
limited supply of PGF2o< compound. Because of this, more significance 
might be given to the 27 day increased ovarian progesterone biosynthesis 
seen in the prostaglandin injected group. The increased progesterone bio-
lynthesis undoubtedly was responsible for the premature sexual development 
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Had the dosage of PGF2°' per gram of body weight been constant 
ctudng this growth period, perhaps more obvious biological responses 
would have been seen. This provides another area for future investigation. 
The dramatic effect of premature sexual development in immature rats 
raises several areas for speculation. Knowing that PGF2a can mimic hor-
_,ne actions via increasing cyclic AMP levels in end-organ cell units, one 
can only deduce from this experiment which hormone or hormones were mim-
icked. undoubtedly, small amounts of estrogen(s) play a significant role 
in early ovarian development which also commences the ovarian-pituitary 
cycle (Velardo, 1958), but its exact location and source remains uncer-
tain. Therefore, the daily administration of PGF2~ may have indeed 
mimicked the small amount of endogenous estrogen(s) needed to start 
the maturity of the female reproductive systems. This is supported by 
other investigators who report that all prostaglandins, including F2~ , 
increase steroidogenesis (Speroff and Ramwell, 1970) and comment on their 
wide variability in responses. These results were based on in vitro luteal 
1teroidogenesis and they seemingly contradict the luteolytic effects of 
PGF2<it when large doses were given in vivo to rats (Pharriss and Wyngarden, 
1969). Pharriss and Hunter (1971) tried to solve this apparent contradic-
tion, but their interpretations of the in vitro versus in vivo experiments 
to resolve this problem were difficult and confusing. While higher 
- -doses of PGF2°' cause antagonism to luteolysis, lower doses would bring 
•bout luteolysis. They also stated that PGF2a. administered did not 
ltimulate ovulation but that uterine growth was stimulated when used in 
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conjunction with Pregnant Mare Serum (PMS). Their conclusions were based 
t he assumption that increased ovarian estrogen secretion altered the on 
ratio of estrogen to progesterone thereby stimulating myometrial growth. 
Velardo (1960), proved experimentally that both FSH and LR are 
needed to induce ovulation; thus, might one imply that PGF2 ot. could have, 
indeed, mimicked several endogenous hormones to bring about this early 
•turation? 
The semi-quantitative enzyme histochemical analysis of the ovaries of 
rats injected with PGF2 ~ provided some clues to clarify which hormone or 
hormones the prostaglandin is mimicking. On day 27, the PGF group showed 
the highest reading of all the experimental and control groups, .!:~· 
4.0. This was more than twice the activity as seen in the control ovaries, 
1.8. The effects of this increased progesterone biosynthesis by the 
ovaries is two-fold, (1) progesterone regulates the secretion of FSH and 
1B from the pituitary (Burrows, 1949; Velardo, 1958), thus indirectly 
affecting further ovarian development; and (2) progesterone has specific 
effects on the uterus. 
The gravimetric and enzyme cytochemistry of in ~ prostaglandin 
rat ovaries deserves more scientific attention to determine if such an 
effect was caused exclusively by an increase in progesterone biosynthesis. 
The effects of prostaglandin F2C( on the uterus were not significant 
either gravimetrically or histologically. Obviously, enzymatic histo-
chemical analysis of these uteri will answer some of these perplexing 
' questions. 
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To complicate things more, other investigators are reporting a 
decline in progesterone secretion following PGF2~ infusion using in vivo 
sheep ovaries (Cahmley ~al., 1972) and those of pregnant hamsters (Gut-
tnecht, ~al., 1971). They were measuring plasma progesterone levels 
rather than ovarian biosynthesis, so in fact these results may still be 
compatible. But this does point out the confusion that results from 
analyzing data from.!:.!!. vitro ~in ~studies as suggested earlier. 
perhaps these different effects may represent two different mechanisms of 
action. 
Pharriss and Wyngarden (1969) have proposed that PGF2Q( produces its 
biological effects by venoconstriction producing a local ischemia via 
reduced ovarian blood flow. Therefore, one major difference explaining 
the discrepancies between the in vitro and ~ ~ results is the effect 
of local hemodynamics. Relatively simple experiments could easily be 
devised to answer this question. 
It appears that the prostaglandins are leading us to the common 
meeting ground where cellular communication and metabolism are being inves-
tigated. The cell membrane is indeed coming to be recognized as a most 
important crossroad for a great number of vital activities. How prosta-
glandins mediate this cell-to-cell communication remains yet to be 
explored, but to be sure, the role of prostaglandins with the formation 
O~cyclic AMP is becoming increasingly important. 
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SUMMARY AND CONCLUSION 
A. When prostaglandin F2~ was administered twice daily in 0.075 mg 
ctoses beginning at day 22 in immature female rats, the first significant 
observation was made on day 27 when the activity of P-one-3~-HSD in the 
ovaries was more than twice that present in control ovaries. 
B. premature sexual development as witnessed by early vaginal canali-
sations was produced by the administered PGF2~ and was observed by day 
33 of the experiment. The previous high levels of progesterone biosyn-
thesis undoubtedly played a role since early ovarian steroids are respon-
sible for ovulation and puberty. The exact role of this prostaglandin 
was speculated as being directly responsible via end-organ response or 
indirectly responsible via pituitary gonadotropins. 
c. By day 37, the ovarian progesterone biosynthesis was intensified 
again, but the manifestation revealed by the histochemical assessments 
could be ever so much more revealing when specific stages of estrous cycles 
could be pursued. Further investigations into the effects of prostaglan-
din and the different stages of estrus is therefore suggested, as an 
extension of these original observations. 
D. No gravimetric or histologic differences were noted on the 
pituitary, thyroid and uterus as they pertained to PGF2d.. administration. 
There were some minor weight variations but were not statistically signifi-
cant. 
E. Aspirin was used as a prostaglandin antagonist to determine 
if any contrasting data would be obtained as it pertains to PGF2~ . 
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The concentration of injectable aspirin was determined and as the experi-
.-nt progressed, the body weights failed to keep up with the controls, 
and with the presence of rough hair coats, a status of aspirin toxicity 
was suspected. This has undoubtedly interferred with some of the report-
able data obtained. The delay of sexual maturity was the most obvious 
contrasting phenomenon by the aspirin-administered rats. This delay 
could not be explained adequately by antagonizing prostaglandin·because 
of the suspected toxicity present. This may prove a fruitful area for 
further research. 
F. Both FSH and LR groups by day 27 had significantly larger 
body weights which were not in accord with pure FSH and IJl responses. 
This complicated the other results observed in these groups ie. uterine 
responses and ovarian progesterone biosynthesis. Having a pure compound 
of FSH and IJl would have enabled a reliable pattern of organ growth and 
development to which the prostaglandin grdup could be compared. Further 
experimental trials using such compounds in conjunction with and without 
prostaglandins would be revealing. 
G. Thus, in sum, the hall-mark noted effects of PGF2d,. in these 
experiments are two in number: (a) PGF2~ induced early vaginal canaliza-
tion, and (b) PGF2~ elicited comparatively high intensities of the pro-
gesterone precursor in the maturing ovary. 
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VAGINAL OPENINGS AND THE GRAVIMETRIC COMPARISONS OF BODY, THYROID, 'PrrtJI.TAR.Y AND UTERI.NE 'WEl.GMS 01!' nn?. 
NORMAL CONrROL GROUPS OF ALB I.NO RATS 
Age 
in Vaginal 
Days ~ Bodl'.: Wt. Thl:roid Wt. Pituitarl'.: Wt. Uterus Wt. 02enin~s(c) 
22 g, mg(a) 41+5 .'3 (b) 4.7 2.2 20.2 0/10 
range 36-=51 3.0-6.8 1.3-2.8 17.4-24.7 
mg% 11.5+2. 2 5.4+1. l 50.0+7 .6 
range 8.3-15.5 3.6:-7.1 34.9:-62.2 
27 g, mg 59+7. 5 6.9 3.2 34.0 0/10 
range 51:'73 5.7-8.7 2.8-4.0 26.5-52.8 
mg% 11.7+1.0 5.5-t-0.15 56. 6+10. 6 
range 13.3:-10.5 4. 7:'6.5 43.2:-73.4 
33 g, mg 92+6 .4 8.4 4.4 85.2 0/9 
range 84:-102 6.1-12.4 4.1-5.2 46.8-165.2 
mg% 9 .O+l. 9 4.8-t-0.4 92.0+46.9 






Item Body Wt. Thyroid Wt. Pituitary wt. uterus Wt. 
g, mg 123+12. 3 9.6 5.2 114.2 
range ln:-149 6.9-12.7 3.6-7.1 50.8-219.9 
mg% 7. 9+1. i 4.2+o.7 92 .5+31. 9 
range 6.2:-9.6 3. 0:-5 .1 42.7:-157.1 
8 Body weights are shown in grams (g), organ weights in milligrams (mg). 




cFigure before diagonal represents number of rats with vagina open at time of necropsy; figure 







VAGINAL OPENINGS AND THE GRAVIMETRIC COMPARISONS OF BODY, THYROID, PTIUTIARY AND 
UTERINE WEIGHT OF 27 DAY OLD GROUPS TO CONTROL GROUPS OF ALBINO RATS 
Item Body Wt. Thyroid Wt. Pituitary Wt. Uterus Wt. Vaginal Openings(c) 
g, mg(a) 60+7.6(b) 7.1 3.3 34.3 0/10 
range 50:-71 5.7-8.6 2.9-4.1 26.5-52 6 
mg% 11. 5+1. 7 5.5+o.5 58.2+9.3 
4. 9-6.6 45.7-74.1 -range 10.4-13.8 
g, mg 55+5. 5 6~7 3.0 34 2 0/10 
range 49:-69 5. 7-8.2 2.6-3.3 22.2-48 7 
mg% 11. 8+1.1 5.5+o.5 61. 5+10.4 
range 9.8-13.9 4.8:-5.9 53.2:-82.1 
g, mg 54-+4.5 6.0 3.4 26.6 0/8 
range 47:-62 5.2-7.0 3.0-4.2 18.8-37.2 
mg% 11.2+o.9 6. 3+1.1 49.0+8.5 
range 10 2+13.0 4.8:-8.4 41. 9:-60.4 
Pro ba bi li ty <0.05 
- Continued -
Group Item Body Wt. Thyroid Wt. Pituitary Wt. Uterus Wt. Vaginal Openings 
FSH g, mg 68-+8.l 6.8 3.5 49.4 0/10 
range 56:-84 5.8-9.2 2.9-4.8· 36.0-73.6 
mg% 10.1+1.4 5.1+1.0 64-9+13. 5 
Range 8.1-12 1 3.9:-7.1 54.6:-87.6 
Pro ba bi 1i ty <0.02 
LR g, mg 65+3.6 7.3 4.1 124.5 0/10 
range 60:-71 6.2-8.2 3.6-4.9 74.8-193.0 
mg% 11.2+1.0 6.3+o.6 191. 5+62. 8 
range 9 .1-r2. 5 5.5:-7.3 110. o:-3oi. 6 
Probability <0.01 <0.01 <0.001 
aBody weights are shown in grams (g), organ weights are shown in milligrams per 100 grams body 
weight (mg%). 
bAverage weight ± the standard deviation. 
cFigure before diagonal represents number of rats with vagina open at time of necropsy; figure 
after diagonal represents number of rats in age group. 
VAGINAL OPENINGS AND THE GRAVIMETRIC COMPARISONS OF BODY, THYROID, 'PITUITARY A.ND 
UTERINE WEIGHT OF 33 DAY OI.D GROUPS TO CONTROL GROUPS OF ALBINO RA.TS 
GrouI! Item Bodz wt. Thyroid Wt. Pituitarx wt. Uterus Wt. Vaginal 012enings(c) 
Alcohol g' mg (.a) 93+7 .4(b) 8.8 4.6 87.5 1/10 
Control range 807105 6.3-12.9 4.1-5.3 48.2-180.8 
mg% 9. 5+2. 5 4.9+-0.5 93.6-146.6 
range 6.8713.9 4.175.6 51. 37180 
PGF2ci1. g' mg 90+11.2 8.4 4.3 75.9 9/10 
range 787109 6.0-10.8 3.5-4.8 44.1-154.5 
mg% 9 .4+2. 0 4.9+1. l 82. 2-141. 5 
range 5.9712.8 4.276.0 39.37153.0 
Probability <0.001 
Aspirin g, mg 89+12. 7 8.9 4.5 70.9 1/7 
range 787112 7.0-11.4 3.7-5.7 44.3-156.2 
mg% 10. 0+2 .4 5.1+-0.5 78.5-144.2 
range 7.5-l3.8 4.4:-5.6 44.8:-173.6 
- Continued -
GrouE Item Bod~ Wt. Thrroid Wt. Pituitarr wt. Uterus Wt. va~inal Openin~s 
FSH g' mg 103+12 .2 9.3 4.9 149.9 10/10 
range 89-l25 7.9-11.3 4.0-6.0 89.5-216.4 
mg% 8.9+1.0 4.8-+-0.5 143.1+39 .1 
range 7.3:-10.9 4.o:-s.6 89.5-l97.9 
Probability <0.05 <0.02 <0.001 
g' mg 101+16.2 10.0 5.9 204.l 9/9 
range 64-117 7.8-11.7 4.0-7.l 145.6-290.4 
mg% 10. 0+1. 2 5.9-+-0.7 210 .4+77. 9 
range 8.9-12.2 4.6:-7.1 136.2:-259.3 
Probability <0.001 <0.001 <0.001 
8 Body weights are shown in grams (g), organ weights are shown in milligrams per 100 grams body 
weight (mg%). 
bAverage weight ± the standard deviation. 
cFigure before diagonal represents number of rats with vagina open at time of necropsy; figure 
after diagonal represents number of rats in age group. 
TABU: N 
VAGINAL OPENINGS AND THE GRAVIMETRIC COMPARISONS OF BODY, THYROID AND UTERINE 
WEIGHTS OF 37 DAY OLD GROUPS TO CONTROL GROUPS OF ALBINO RATS 
Groue Item Body wt. Thyroid Wt. Pituitary Wt. Uterus Wt. Vaginal Openings(c) 
Alcohol g, mg(a) 122+13.9(b) 9.7 5.2 117 .4 10/10 
Control range 109:-155 7 .2-11.9 4.1-7.l 51. 3-221.4 
mg% 8.0+1.0 4.3-+-0.8 96.2+33.0 
range 6.4:-9.3 3.1:-5.3 42.4:-164.0 
PGF2« g, mg 120+15.6 10.0 5.2 107 .9 9/9 
range 88-l39 8.0-13.6 4.2-6.1 62.8-143.1 
mg% 8. 6+1. 9 4.3-+-0. 7 80. 3+29.0 
range 5.8:-11.3 3.3:-5.8 53.7:-132.3 
Aspirin g, mg 110+12 .1 9.2 5.2 109.3 6/8 (75%) 
range 85-122 6.8-10.8 4.1-6.2 36.5-167.1 
mg% 8.4+1.0 4.8-+-0.6 103. 2-+43 .1 
range 7.0:-10.1 4.o:-5.6 41. 7-l62. 6 

























6. 9:-11. 5 
10.4 
8.6-11.3 
Pituitary Wt. Uterus Wt. vaginal Openings 
6.2 147. 3 10/10 
5.0-7.0 113.3-207.2 
4.9+-0.4 117 .0+28. 6 
4.2°=5. 1 79.8-l63.9 
<0.02 <O.l 
6.7 161.2 10/10 
5. 1-8.0 138.7-195.7 
5.4+o. 8 128.4+11. 8 
3.9:-6.2 105.9:-147.4 
<0.01 <0.01 
aBody weights are shown in grams (g), organ weights are shown in milligrams per 100 grams body 
weight (mg%). 
bAverage weight ± the standard deviation. 
cFigure before diagonal represents number of rats with vagina open at time of necropsy; figure 
after diagonal represents number of rats in age group. 
TABLE V 
SUMMARIZED DATA BASED ON SEMI-QUANTITATIVE HISTOCHEMICAL ANALYSIS OF PREGNENOLONE-3B-RSD A.CTIVITY IN 
















3. o+o. 71 
2 -4 
5 













































aArithmetic average + the standard deviation based on semi-quantitative histochemical estimates of 
pregnenolone-3B-HSD activity as observed on ovarian sections. Scale ranges from +l to +5. 
bRange 
cNumber of rats in group. 
GRAVIMETRIC COMPARISON OF THYROID GLA.NDS OF RATS BASED UPON THE WEIGHT OF THE ORGA.N 'PER 100 G'RA.MS 
OF BODY WEIGHT (mg%) 
12 0-0 Control 
>HC PGF2C( 










22 27 33 37 
Days of Age 
TExr FIGURE II 
GRAVIMETRIC COMPARISONS OF THE PITUITARY GI.ANDS OF RATS BASED ON THE ORGAN WEIGH.TS PER 100 GRAMS OF 







22 27 33 








TEX! FIGURE III 
GRAVIMETRIC COMPARISONS OF THE UTERINE WEIGHTS OF RATS BASED UPON THE ORGAN WEIGHT PER 100 GRAMS O'F 
BODY WEIGHT (mg%) 
Control 0-0 









22 27 33 37 
Days of Age 
TEXI FIGURE r1 
SUMMARY OF DATA CONCERNING VAGINAL OPENINGS OF RATS DETERMINED AT TIME OF NECROPSY, BASED ON A P'ER-
CENrAGE OF VAGINAL OPENINGS 











27 33 37 
Age in Days 
TExr FIGURE V 
SEMI-QUANTITATIVE COMPARISONS OF PREGNENOLONE-3B-HSD ACTIVITY IN THE OVARms OF RATS BASED ON A REIATIVE 

















Introductory Note to Plates 
All photomicrographs are of cross sections of ovaries. Photomicro-
graphs were taken using Polaroid type 107 film and a Wild microscope. 





Photomicrographs of rat ovarian sections, normal H&E is portrayed in 
Figure 1, the control is Figure 2 and Figure 3 was incubated with preg-
nenolone demonstrating the appearance of pregnenolone-3~-hydroxysteroid 
dehydrogenase (P-one-3~-HSD) in the form of precipitated deposits which 
localize the sites of the biosynthesis of progesterone. These photo-
micrographs were semi-quantitatively evaluated on a sc,ale of 0 to +5 





1. Control ovarian section stained with H&E to demonstrate the 
appearance of the ovarian structure (lOOX). 
2. Control section of ovary incubated without pregnenolone. 
resents a zero reaction (lOOX). 
3. Represents a +l reaction. 
visible. 
very little diformazan deposits 
Rep-
PIATE I 















Photomicrographs of rat ' ovarian sections which were incubated with 
pregnenolone demonstrating the appearance of pregnenolone-3~-hydroxy- , 
steroid dehydrogenase (P-one-3~-HSD) in the form of precipitated de-
posits which localize the sites of the biosynthesis of progesterone. 
These photomicrographs were semi-quantitatively evaluated on a scale of 
51 
0 to +5 depending upon the amount of precipitate formed. All photographs 
are at lOOX. 
Fig. 4. Represents a +2 reaction. Few deposits are in evidence indica-
ting slight P-one-3~-HSD activity. 
Fig. 5. Repre.sents a +3 reaction. M::>re discrete deposits are visible. 
Fig. 6. Represents a -+4 reaction. Larger areas of more dense P-one-
3~-HSD activity are visible. 
PIATE II 
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Plate III 
Photomicrographs of rat ovarian sections which were incubated with 
pregnenolone d~monstrating the appearance of pregnenolone-3~-hydroxy­
steroid' dehydrogenase (P-one-3~-HSD) in the form of precipitated de-
posits which localize the sites of the biosynthesis of progesterone. 
These photomicrographs were semi-quantitatively evaluated on a scale of 
0 to +5 depending on the amount of precipitate formed. All photographs 
are at lOOX. 
Fig. 7. Represents a +5 reaction. Confluent areas of dense deposits 





PI.ATE . III 
Fig. · 7. 
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Plate IV 
Photomicrographs of sections of ovaries from the non-injected 
control rats which were ,incubated with pregnenolone and nictotinamide 
adenine dinucleotide (NAD) to localize the activity sites of progesterone 
biosynthesis. 
Fig. 8. Ovarian section from a 33 day bld non-injected control rat, 
showing +2 P-one-3~-HSD activity in the interstitial tissue (lOOX). 
Fig. 9. Ovarian section from a 37 day old non-injected control rat, 
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Plate V 
Photomic-rographs· of sections of ovaries from the PGF20< injected 
rats whi~h were incubated with pregnenolone to localize the sites of 
progesterone biosynthesis. 
Fig. 10. Ovarian section from a 27 day old PGF20( injected rat showing 
maximum +5 P-one-3~-HSD activity in the intestitial tissue and in 
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